Clinical Trials Directory

Trials / Completed

CompletedNCT00583414

Endovascular Exclusion of Abdominal Aortic Aneurysms in High Risk Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
401 (actual)
Sponsor
The Cleveland Clinic · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the role of abdominal aneurysm and iliac aneurysm exclusion using an endovascular prosthesis.

Detailed description

This study is a prospective, non-randomized evaluation of endovascular aneurysm repair in high-risk patients. The purpose of this study is to determine whether this endovascular prosthesis is safe and effective for the intended use of treating AAA/iliac aneurysm in patients who are at high risk for standard aneurysm surgical repair. Up to 400 patients will be enrolled at the Cleveland clinic Foundation. Baseline procedures may include angiogram, intravascular ultrasound, CT scan, physical exam, blood work and ankle-brachial index. The endovascular prosthesis is placed in the operating room under regional or general anesthesia and the procedure length is approximately 2-3 hours. Follow up evaluations will be done at 1 month, 6 months (if clinically necessary), 12 months and yearly, and may include a physical exam, CT scan, KUB, ultrasound, blood work, and an ankle-brachial index.

Conditions

Interventions

TypeNameDescription
DEVICEEndovascular Aneurysm RepairEndovascular exclusion of aneurysm

Timeline

Start date
1998-09-01
Primary completion
2017-10-01
Completion
2017-10-01
First posted
2007-12-31
Last updated
2019-01-25
Results posted
2019-01-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00583414. Inclusion in this directory is not an endorsement.